Careful approaches are needed over biosimilar business

Published: 2009-08-21 06:59:00
Updated: 2009-08-21 06:59:00
The government will need to work out measures to push up with the controversial biosimilar business in more cautious manner, experts claimed.

They argued that generic drug companies are ready to make cheaper versions of some of the biotech industry’s best sellers, the process for making biolog...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.